CTB
CAS No. 451491-47-7
CTB( Cholera Toxin B subunit )
Catalog No. M28749 CAS No. 451491-47-7
CTB (Cholera Toxin B subunit) is an activator of p300 histone acetyltransferase and induces apoptosis in MCF-7 cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 53 | Get Quote |
|
| 10MG | 87 | Get Quote |
|
| 25MG | 178 | Get Quote |
|
| 50MG | 295 | Get Quote |
|
| 100MG | 475 | Get Quote |
|
| 500MG | 1017 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCTB
-
NoteResearch use only, not for human use.
-
Brief DescriptionCTB (Cholera Toxin B subunit) is an activator of p300 histone acetyltransferase and induces apoptosis in MCF-7 cells.
-
DescriptionCTB (Cholera Toxin B subunit) is an activator of p300 histone acetyltransferase and induces apoptosis in MCF-7 cells.(In Vitro):dose-dependent.
-
In VitroCell Viability Assay Cell Line:MCF-7 cell Concentration:0-200 μM Incubation Time:24 hours Result:Inhibit viability with an IC50 of 85.43 μM.Apoptosis Analysis Cell Line:MCF-7 cell Concentration:85.43 μM Incubation Time:24, 48 and 72 h Result:Iinduced time-dependence apoptosis.
-
In Vivo——
-
SynonymsCholera Toxin B subunit
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorD2 receptor|5-HT2A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number451491-47-7
-
Formula Weight686.45
-
Molecular FormulaC32H25Cl2F6N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (290.93 mM)
-
SMILESCCOc(cccc1)c1C(Nc(cc1)cc(C(F)(F)F)c1Cl)=OCCOc(cccc1)c1C(Nc(cc1)cc(C(F)(F)F)c1Cl)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Schotte A, et al. In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used. Jpn J Pharmacol. 1995 Dec;69(4):399-412.
molnova catalog
related products
-
AW68
AW68 is a potential small molecule BRD4 inhibitor that prevents and treats BRD4-related diseases and can be used in cancer research.
-
Diflunisal
Diflunisal, a salicylate derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with pharmacologic actions similar to other prototypical NSAIAs.
-
PBRM1-BD2-IN-8
PBRM1-BD2-IN-8 (compound 34) is a potent PBRM1 Bromodomain inhibitor with PBRM1-BD2 Kd of 4.4 μM, PBRM1-BD2 IC50 of 0.16 μM, and PBRM1-BD5 Kd of 25 μM; PBRM1-BD2-IN-8 shows anti-cancer activity.
Cart
sales@molnova.com